Compound Detail
CHEMBL4241824
GSK-3008348 FREE BASE Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Cc1cc(C)n(-c2cccc([C@H](CC(=O)O)CN3CC[C@@H](CCc4ccc5c(n4)NCCC5)C3)c2)n1
Basic Information
| ChEMBL ID | CHEMBL4241824 |
| Name | GSK-3008348 FREE BASE |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | ZMXBIIQMSGOIRZ-RCZVLFRGSA-N |
7
Targets
25
Activities
4
Assay Types
30
PK Parameters
16
Publications
1
Known Names
Molecular Properties
487.6
MW (Da)
4.76
ALogP
6
HBA
2
HBD
83.3
PSA (Ų)
0.45
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Activity Summary
Kd 14 meas. best 10.8
IC50 8 meas. best 9.0
Ki 2 meas. best 11.0
EC50 1 meas. best 9.8
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Integrin alpha-V/beta-6 CHEMBL2111416 | Ki | 11.0 | 10.7 | 0.0 | 2 |
| Integrin alpha-V/beta-6 CHEMBL2111416 | Kd | 10.8 | 10.75 | 0.0 | 2 |
| Integrin alpha-V/beta-6 CHEMBL2111416 | EC50 | 9.8 | 9.8 | 0.2 | 1 |
| Integrin alpha-5/beta-1 CHEMBL2095226 | Kd | 9.59 | 8.295 | 0.3 | 4 |
| Integrin alpha-V/beta-6 CHEMBL2111416 | IC50 | 9.0 | 8.7 | 1.0 | 2 |
| Integrin alpha-V/beta-1 CHEMBL2111407 | Kd | 8.59 | 8.59 | 2.6 | 2 |
| Integrin alpha-V/beta-8 CHEMBL3430892 | Kd | 8.56 | 8.56 | 2.7 | 2 |
| Integrin alpha-V/beta-8 CHEMBL3430892 | IC50 | 7.8 | 7.8 | 15.8 | 1 |
| Integrin alpha-V/beta-3 CHEMBL1907598 | Kd | 7.74 | 7.74 | 18.2 | 2 |
| Integrin alpha-V/beta-5 CHEMBL2096675 | Kd | 7.68 | 7.68 | 20.9 | 2 |
| Integrin alpha-V/beta-1 CHEMBL2111407 | IC50 | 7.3 | 7.3 | 50.1 | 1 |
| Integrin alpha-V/beta-5 CHEMBL2096675 | IC50 | 6.9 | 6.9 | 125.9 | 1 |
| Integrin alpha-V/beta-3 CHEMBL1907598 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.9 | 4.7 | 12589.2 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 51.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 25.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 15.0 | % | Rattus norvegicus |
| CL | 21.0 | % | Canis lupus familiaris |
| CL | 50.0 | % | Canis lupus familiaris |
| CL | 3.0 | mL.min-1.g-1 | Mus musculus |
| CL | 0.55 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 0.53 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 0.58 | mL.min-1.g-1 | Homo sapiens |
| CL | 15.3 | mL.min-1.g-1 | Mus musculus |
| CL | 9.45 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 1.73 | mL.min-1.g-1 | Canis lupus familiaris |
| CL | 0.86 | mL.min-1.g-1 | Homo sapiens |
| CL | 24.0 | % | Rattus norvegicus |
| CL | 70.0 | % | Rattus norvegicus |
| Cmax | 6.152 | nM | Rattus norvegicus |
| Cmax | 61.52 | nM | Rattus norvegicus |
| Cmax | 112.79 | nM | Canis lupus familiaris |
| F | 2.0 | % | Rattus norvegicus |
| F | 40.0 | % | Rattus norvegicus |
| F | 27.0 | % | Canis lupus familiaris |
| F | 21.0 | % | Rattus norvegicus |
| F | 54.0 | % | Rattus norvegicus |
| T1/2 | 0.04333 | hr | Homo sapiens |
| T1/2 | 0.8 | hr | Rattus norvegicus |
| T1/2 | 1.2 | hr | Canis lupus familiaris |
| T1/2 | 7.0 | hr | Homo sapiens |
| T1/2 | 11.0 | hr | Homo sapiens |
| Tmax | 0.5 | hr | Rattus norvegicus |
| Tmax | 0.2 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30215258 | 10.1021/acs.jmedchem.8b00959 | ADMET | 35 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Rattus norvegicus | 14 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Integrin alpha-V/beta-6 | 13 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Unchecked | 10 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Canis familiaris | 8 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Integrin alpha-5/beta-1 | 4 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Integrin alpha-V/beta-5 | 3 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Integrin alpha-V/beta-3 | 3 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Integrin alpha-V/beta-1 | 3 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Integrin alpha-V/beta-8 | 3 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 30215258 | 10.1021/acs.jmedchem.8b00959 | No relevant target | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine